Significant regulatory progress has been made under CEO Charles Scharf, as evidenced by the closing of the seventh regulatory ...

California Water Service (Cal Water), has signed contracts to buy the water utility assets of Palm Mutual Water Company and ...

Castle Biosciences, Inc. (NASDAQ:CSTL)’s Dx-Melanoma test, which evaluates a 31-gene expression profile, offers significant, ...

Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...

Despite a recent third-quarter earnings miss, reporting adjusted EPS of $0.79 versus the expected $0.89 and revenue of $15.31 ...

The tool joins Illumina, Inc. (NASDAQ:ILMN)’s AI portfolio, including SpliceAI and PrimateAI-3D, and integrates with its ...

Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking ...

These results strengthen the scientific foundation for Lantern Pharma Inc. (NASDAQ:LTRN)’s FDA Rare Pediatric Disease ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) has announced a major milestone in its STARLIGHT-1 Phase I/II clinical trial, ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

On Thursday, Morgan Stanley lifted NVIDIA Corporation (NASDAQ: NVDA )’s stock price target to $170 from $160, while ...